Lung cancer is the leading cause of cancer death in the United States. It accounts for more cancer deaths in women than breast, ovarian and uterine cancer combined. Studies have shown distinct differences in lung cancer between men and women:
Women are more likely to develop certain types of lung cancer (such as adenocarcinoma and small cell carcinoma).
Women have a better survival rate overall than men.
Female smokers are less likely to develop lung cancer than their male counterparts.
Female non-smokers are more likely to develop the disease.
Lung cancer tumors in women have genetic differences that make them more responsive to treatment.
As the first hospital in the nation to focus on gender medicine in a comprehensive way, Brigham and Women’s Hospital (BWH) has developed a targeted evaluation and treatment program that recognizes that lung cancer develops and progresses differently in women than in men.
The Women's Lung Cancer Program comprises surgeons, radiation oncologists, medical oncologists, pulmonologists, cardiologists, radiologists, pathologists, nurses, physical therapists, dietitians and social workers—all experts in the advanced care of women with lung cancer. The Program is part of The Lung Center at BWH and offers a wide range of support services, including the Women's Lung Cancer Forum, nutritional services and post-operative services for women undergoing surgical therapy for lung cancer.
Our physician-scientists are engaged in ongoing research, leading to progress in gender-specific lung cancer discoveries and bringing new therapies and hope to women with lung cancer.
The Lung Center is located at Brigham and Women’s Hospital (BWH) at the 15 Francis Street entrance. Thoracic surgery, pulmonary and critical care medicine and thoracic imaging are adjacent to one another, making accessibility and appointment scheduling seamless.